Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 10, 2002, Pages 1065-1071

  Rinaldi, Sabina ^a   Geay, Annabelle ^b   Déchaud, Henri ^b   Biessy, Carine ^a   Zeleniuch Jacquotte, Anne ^c   Akhmedkhanov, Arslan ^c   Shore, Roy E ^c   Riboli, Elio ^a   Toniolo, Paolo ^c   Kaaks, Rudolf ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ESTROGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ARTICLE; BINDING COMPETITION; CALCULATION; CANCER RISK; CLINICAL ARTICLE; COHORT ANALYSIS; CORRELATION FUNCTION; DIALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE DETERMINATION; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; STANDARD; TESTOSTERONE BLOOD LEVEL; THEORY; VALIDATION PROCESS;

AGED; COHORT STUDIES; EPIDEMIOLOGIC STUDIES; ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASMS; POSTMENOPAUSE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0036800654     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Thomas, H. V., Reeves. G. K., and Key, T. J. Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control, 8: 922-928, 1997
2. Akhmedkhanov, A., Zeleniuch-Jacquotte, A., and Toniolo, P. Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann. N. Y. Acad. Sci. 943: 296-315, 2001
3. Potischman, N., Hoover, R. N. Brinton, L. A., Siiteri, P., Dorgan, J. F., Swanson, C. A., Berman, M. L., Mortel, R., Twiggs, L. B., Barrett, R. J., Wilbanks, G. D., Persky, V., and Lurain, J. R. Case-control study of endogenous steroid hormones and endometrial cancer. J. Natl. Cancer Inst. (Bethesda), 88: 1127-1135, 1996
4. Anderson, D. C. Sex-hormone-binding globulin. Clin. Endocrinol. (Oxf.), 3: 69-96, 1974
5. Pardridge, W. M. Plasma protein-mediated transport of steroid and thyroid hormones. Am. J. Physiol., 252: E157-E164, 1987
6. Sodergard, R., Backstrom, T., Shanbhag, V., and Carstensen, H. Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J. Steroid Biochem., 16: 801-810, 1982
7. Bernstein, L., and Ross, R. K. Endogenous hormones and breast cancer risk. Epidemiol. Rev., 15: 48-65, 1993
8. Pardridge, W. M. Serum bioavailability of sex steroid hormones. Clin. Endocrinol. Metab. 15: 259-278, 1986
9. Dunn, J. F., Nisula, B. C., and Rodbard, D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J. Clin. Endocrinol. Metab., 53: 58-68, 1981
10. Dechaud, H., Lejeune, H., Garoscio-Cholet, M., Mallein, R., and Pugeat, M. Radioimmunoassay of testosterone not bound to sex-steroid-binding protein in plasma. Clin. Chem., 35: 1609-1614, 1989
11. Tremblay, R. R., and Dube, J. Y. Plasma concentrations of free and nonTeBG bound testosterone in women on oral contraceptives. Contraception, 10: 599-605, 1974
12. Loric, S., Guechot, J. Duron, F., Aubert, P., and Giboudeau. J. Determination of testosterone in serum not bound by sex-hormone-binding globulin: diagnostic value in hirsute women. Clin. Chem., 34: 1826-1829, 1988
13. Slaunwhite, R. W. The binding of estrogens, androgens and progesterone by plasma protein in vitro. Steroids, 478-494, 1960
14. Cooke, R. R., McIntosh, J. E., and McIntosh, R. P. Circadian variation in serum free and non-SHBG-bound testosterone in normal men: measurements, and simulation using a mass action model. Clin. Endocrinol. (Oxf.), 39: 163-171, 1993
15. Vlahos, I., MacMahon, W., Sgoutas, D., Bowers, W., Thompson, J., and Trawick, W. An improved ultrafiltration method for determining free testosterone in serum. Clin. Chem., 28: 2286-2291, 1982
16. 14C]glucose. Clin. Chim. Acta, 200: 13-22, 1991
17. Dowsett, M., Mansfield, M. D., Griggs, D. J., and Jeffcoate, S. L. Validation and use of centrifugal ultrafiltration-dialysis in the measurement of percent free oestradiol in serum. J. Steroid Biochem., 21: 343-345, 1984
18. Green, P. J., and Yucis, M. J. Free-testosterone determination by ultrafiltration, and comparison with dialysis. Clin. Chem., 28: 1237-1238, 1982
19. Wheeler, M. J., and Nanjee, M. N. A steady-state gel filtration method on micro-columns for the measurement of percentage free testosterone in serum. Ann. Clin. Biochem., 22: 185-189, 1985
20. Greenstein, B. D., Puig-Duran, E., and Franklin, M. Accurate, rapid measurement of the fraction of unbound estradiol and progesterone in small volumes of undiluted serum at 37°C by miniature steady-state gel filtration. Steroids, 30: 331-341, 1977
21. Csako, G. Free hormone measurements. In: Immunoassay. pp. 423-481. Academic Press, 1996
22. Vermeulen, A., Stoica, T., and Verdonck, L. The apparent free testosterone concentration, an index of androgenicity. J. Clin. Endocrinol. Metab., 33: 759-767, 1971
23. Vermeulen, A., Verdonck, L., and Kaufman, J. M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab., 84: 3666-3672, 1999
24. Pearlman, W. H., and Crepy, O. Steroid-protein interaction with particular reference to testosterone binding by human serum. J. Biol. Chem., 242: 182-189. 1967
25. Rinaldi, S., Dechaud, H., Biessy, C., Morin-Raverot, V., Toniolo, P., Zeleniuch-Jacquotte, A., Akhmedkhanov, A., Shore, R. E., Secreto, G., Ciampi, A., Riboli, E., and Kaaks, R. Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women. Cancer Epidemiol. Biomark. Prev., 10: 757-765, 2001
26. Pugeat, M., Garrel, D., Estour, B., Lejeune, H., Kurzer, M. S., Tourniaire, J., and Forest, M. G. Sex steroid-binding protein in nonendocrine diseases. Ann. N. Y. Acad. Sci., 538: 235-247, 1988
27. Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., and Pasternack, B. S. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl. Cancer Inst. (Bethesda), 87: 190-197, 1995
28. Hankinson, S. E., Willett, W. C., Manson, J. E., Colditz, G. A., Hunter, D. J., Spiegelman, D., Barbieri, R. L., and Speizer, F. E. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst. (Bethesda), 90: 1292-1299. 1998
29. Cauley, J. A., Lucas, F. L., Kuller, L. H., Stone, K., Browner, W., and Cummings, S. R. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann. Intern. Med., 730: 270-277, 1999
30. Longcope, C., Hui, S. L., and Johnston, C. C., Jr. Free estradiol, free testosterone, and sex hormone-binding globulin in perimenopausal women. J. Clin. Endocrinol. Metab., 64: 513-518, 1987
31. Berrino, F., Muti, P., Micheli, A., Bolelli, G., Krogh, V., Sciajno, R., Pisani, P., Panico, S., and Secreto, G. Serum sex hormone levels after menopause and subsequent breast cancer. J. Natl. Cancer Inst. (Bethesda), 88: 291-296, 1996